An Aptamer‐Conjugated AIEgen for Targeted Bioimaging and Photodynamic Therapy of Cancer Cells
Chemistry – A European Journal · 17.07.2025 · 31 (40)
DOI: 10.1002/chem.202501209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 01.07.2025. Verfasst von Yi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Chongqing Medical University, 1 Yixueyuan Road, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Photochemotherapy, Aptamers, Nucleotide, Photosensitizing Agents, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Creative Research Group of CQ University, Program for Youth Innovation in Future Medicine, Chongqing Medical University.
Abstract (Originalsprache)
Photodynamic therapy (PDT) has emerged as a promising noninvasive treatment for cancer and other diseases. Aggregation‐induced emission (AIE) photosensitizers are excellent candidates for enhancing the efficacy of image‐guided PDT due to their unique properties. DNA‐modified AIE luminogens (AIEgens) offer an effective approach for nucleic acid detection and biospecies sensing, but their applications in tumor cell imaging and image‐guided PDT have been rarely reported. Herein, we designed a light‐up probe, named ApApt, for targeted imaging and image‐guided PDT of cancer cells. The probe was prepared by conjugating AIEgen with aptamer and displayed specific targeting ability to EpCAM (epithelial cell adhesion molecule)‐positive cancer cells. ApApt exhibits good water solubility and shows very low emission in aqueous solution. However, it emits strong fluorescence as a result of the restricted intramolecular motion (RIM) activation of AIEgens, which is triggered by the specific binding between the aptamer SYL3C and EpCAM protein. Upon delivery to cancer cells, ApApt efficiently generates ROS for targeted PDT under light irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medicine, Chongqing Medical University, 1 Yixueyuan Road, Chongqing, 400016, China.
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, 1 Yixueyuan Road, Chongqing, 400016, China.
ORCID-Profile: Wenjun Miao
Förderung
- National Natural Science Foundation of China
- Creative Research Group of CQ University
- Program for Youth Innovation in Future Medicine, Chongqing Medical University
- Natural Science Foundation of Chongqing
- Chongqing Medical University
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Chen, Y., Zhao, M., Yang, P., Wang, Y., Zou, Y., & Miao, W. (2025). An Aptamer‐Conjugated AIEgen for Targeted Bioimaging and Photodynamic Therapy of Cancer Cells. Chemistry – A European Journal, 31(40). https://doi.org/10.1002/chem.202501209
Vancouver
Chen Y, Zhao M, Yang P, Wang Y, Zou Y, Miao W. An Aptamer‐Conjugated AIEgen for Targeted Bioimaging and Photodynamic Therapy of Cancer Cells. Chemistry – A European Journal. 2025;31(40). doi:10.1002/chem.202501209
BibTeX
@article{Chen2025,
author = {Chen, Yi and Zhao, Maochao and Yang, Pan and Wang, Yi and Zou, Yuan and Miao, Wenjun},
title = {An Aptamer‐Conjugated AIEgen for Targeted Bioimaging and Photodynamic Therapy of Cancer Cells},
journal = {Chemistry – A European Journal},
year = {2025},
volume = {31},
number = {40},
doi = {10.1002/chem.202501209}
}
EUVIMED